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Early inflammatory mediator gene expression in
two models of traumatic brain injury: ex vivo
cortical slice in mice and in vivo cortical impact in
piglets
David J Graber1*, Beth A Costine2 and William F Hickey1
Abstract
Background: The immunological response during the first 24 hours after traumatic brain injury (TBI) may be a critical
therapeutic interval for limiting the secondary neuronal damage that is influenced by enhanced inflammatory mediator
expression.
Methods: To gain further insight of the early injury response, we examined the expression of several inflammatory
genes by real-time qPCR as a function of time or distance from injury in two distinct mammalian models: an ex vivo
mouse cortical slice injury system and an in vivo piglet model of brain injury.
Results: Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), chemokine ligands 2 (CCL2), 3 (CCL3), 4 (CCL4), and
prostaglandin-endoperoxide synthase 2 (PTGS2) mRNAs increased within 5 h after injury in mouse cortical slices.
Chemokine and PTGS2 mRNAs remained elevated in slices at 24 h, whereas IL-1β and TNF-α expressions decreased from
earlier peak levels. At 24 h after cortical injury in 1-month-old piglets, the expression of CCL2 mRNA was significantly
increased in the lesion core and in the penumbra region. The expression of PTGS2, IL-1β, and TNF-α was variable among
the piglets.
Conclusions: These in vitro and large animal models of cortical injury expand our understanding of the early timing and
spread of the immunological response and can serve as preclinical systems to facilitate the discovery of therapeutic
agents for TBI aimed at regulating inflammatory mediator expression.
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Background
Traumatic brain injury (TBI) is a major health concern
in contact sports and in the military and is the leading
cause of death and disability in children and young
adults. Though progress has been made in prevention
and acute clinical management, a therapeutic that ame-
liorates the disability or mortality associated with TBI re-
mains elusive. Despite the growing awareness of this
public health problem, a greater translational effort in
clinical trials for TBI is needed [1]. Expanding the preclin-
ical research landscape might enhance our understanding
of TBI pathophysiology and facilitate the discovery of
therapeutics that improve recovery outcomes.
Secondary damage in surrounding brain tissue occurs
following the primary insult. Pro-inflammatory mediator
expression is enhanced soon after injury and is followed
several days later by a period of enhanced expression of
anti-inflammatory cytokines [2]. While the immune re-
sponse in the days and weeks after TBI can benefit recov-
ery by clearing cellular debris and producing neurotrophic
factors, disproportionate expression of neurotoxic pro-
inflammatory mediators in the first hours and days after
TBI injury may be detrimental [3]. Thus, an excessive
and/or persistent innate immune response emanating
from the primary injury site may contribute to the severity
of secondary damage.
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The time course of inflammatory mediator expression
is well-established in in vivo rodent models of TBI.
Interleukin-1β (IL-1β) and tumor necrosis factor-α
(TNF-α) increase within the first several hours after cor-
tical injury but then return to baseline levels by 24 h
[4-6]. Chemokine ligands 2 (CCL2, formerly known as
monocyte chemoattractant protein-1), 3 (CCL3), 4 (CCL4),
and prostaglandin-endoperoxide synthase 2 (PTGS2) in-
crease early after injury and remain elevated for 24 h or
longer [7-9]. IL-1β and TNF-α are cytokines associated
with promoting further inflammation, vascular permeabil-
ity, and neurotoxicity. Chemokines recruit inflammatory
cells and enhance synthesis of other inflammatory media-
tors. PTGS2 converts arachidonic acid from the damaged
cell membranes to prostaglandins that modulate local cere-
bral blood flow, recruit inflammatory cells, and enhance
free radical synthesis. In these rodent models, enhancing
cytokine levels or genetic removal alters post-TBI out-
comes highlighting the importance of these mediators in
recovery early after TBI [6,8,10].
While most of our understanding of the early expres-
sion and effects of inflammatory mediators in response
to cortical injury is from the rodent models of TBI, the
timing and contribution of long-term deficits in larger
animal models and in human patients are less clear. An
increase in TNF-α and IL-1β is detected in human cor-
tical tissues early after injury [11]. An increase in CCL2
in human CSF after TBI is found early and remains ele-
vated for over 12 h [8]. CCL3 and CCL4 in cerebral mi-
crodialysis fluid are also elevated for 24 h or longer [12].
It remains unclear whether regulating the synthesis of
these pro-inflammatory mediators will be helpful. Treat-
ing human TBI with synthetic glucocorticoids, which
inhibit the synthesis of many inflammatory mediators,
has not provided favorable results [13]. Safer anti-
inflammatory alternatives to glucocorticoids are being
investigated and show promise [14].
Discovering new therapeutic agents with ideal immu-
nomodulatory characteristics in the CNS may improve
outcomes when administered early after TBI. This dis-
covery effort will be facilitated by filling the gaps in pre-
clinical translational research that exist between cell
culture and rodent models and between rodent models
and human studies. To fill these two gaps, we examine
the early changes in the mRNA expression of inflamma-
tory mediators following cortical injury in two under-
studied systems of TBI. In the first system, we use
mouse cortical slices to evaluate the ex vivo changes in
the mRNA expression of cytokines, chemokines, and
PTGS2 that occur during the first 24 h after injury.
Slices maintain neural cells in their normal microenvir-
onment, and an acute innate immune response occurs
following tissue sectioning. In the second system, we
used piglets to assess the in vivo changes in the
expression of these inflammatory genes 24 h after cor-
tical impact at the lesion core and in the penumbra re-
gion. The piglet brain is gyrencephalic where the
abundance of white matter, anatomy, vasculature, and
pattern of development closely parallels humans [15].
These two systems of cortical injury both demonstrate




The Institutional Animal Care and Use Committee at
Dartmouth College approved all mouse protocols. Adult
(2 to 3 months old) female SJL/J mice (n = 8) were ob-
tained from Jackson Laboratory (Bar Harbor, ME, USA)
and housed for several weeks at the Borwell facility in
Dartmouth’s Center for Comparative Medicine and Re-
search. Acute cultures of cortical slices were prepared as
described previously in more detail [16] with minor
modifications. Brains were rapidly removed after carbon
dioxide-inhaled euthanasia. Four to six slices of cortical
tissue from each mouse brain were immediately trans-
ferred to RNAlater™ RNA Stabilization Reagent (Qiagen
Sciences, Germantown, MD, USA) as a baseline (0 h) or
submerged in 0.5 mL Dulbecco’s Modified Eagle Medium
(Hyclone Laboratories, Logan, UT, USA) supplemented with
fetal bovine serum (Hyclone; 10%) and glutamine (2 mM),
penicillin (50 U/mL), and streptomycin (50 μg/mL) in a
48-well tissue culture tray. In contrast to studies utiliz-
ing slices for electrophysiology, sections are made with-
out the neuroprotectant sucrose as a model of TBI [17].
Slices in media were incubated in 5% carbon dioxide
and high humidity conditions for 0.5, 4.5, 6, or 24 h be-
fore being transferred to RNAlaterTM solution.
Cortical injury in piglets
All protocols were in accordance with the guidelines of
the American Veterinary Association and the National
Institutes of Health (NIH) and were approved by the
Animal Care and Use Committee of Massachusetts
General Hospital. One-month-old male Yorkshire piglets
(n = 6) were obtained from Earle Parsons & Sons, Inc.
(Hadley, MA, USA) and were housed in the MGH
Center for Comparative Medicine. Cortical impact has
been described previously in more detail [18,19]. In brief,
the piglets were anesthetized with ketamine and xyalzine
and 5% isoflurane and maintained with 1% to 2% isoflur-
ane. Atropine and buprenorphine were administered,
and the pigs were intubated and mechanically ventilated.
Core body temperature, end tidal CO2, and oxygen sat-
uration were kept within a narrow range for the duration
of the surgery. A craniectomy was performed at the
junction of the right coronal and sagittal sutures, and
the dura incised to expose the cortical surface. Cortical
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impact to the rostral gyrus was achieved via a spring-
loaded device secured to the skull, and an indentor tip
scaled to 1% of the volume of the brain was displaced
over 4 msec. In injured animals, this produces a lesion
size of 350 ± 50 mm3 or approximately 10% of the vol-
ume of the contralateral hemisphere 1 week after injury
that typically extends down into the gyral white matter
[19,20]. This age of piglet corresponds developmentally
to human toddlers [15]. After injury, the dura was re-
approximated, the skin was closed, and the piglets were
recovered. Twenty-four hours after cortical impact, the
piglets were deeply anesthetized and given buprenor-
phine, and the burr hole expanded from the previous
day and a new burr hole placed contralateral to the in-
jury and dura to access cortical tissue. The piglets were
euthanized with an injection of Euthasol, and cortical
samples (2 cm3) were obtained immediately from the le-
sion core, penumbra, 2 cm anterior to the injury, and
corresponding cortical region from the contralateral
hemisphere. The lesion core was the region directly
under the indentor tip. The penumbra was the region
surrounding the lesion core. Samples were divided and/
or snap frozen on dry ice, stored at −80°C freezer, and
then immersed in RNAlaterTM solution prior to RNA
isolation.
Real-time reverse transcriptase PCR
After removing excess RNAlater™ solution from the pig-
let or mouse cortical tissues, RNA was extracted using
TRIzol Reagent (Life Technologies, Carlsbad, CA, USA).
The eluted RNA was quantified by spectrophotometry,
and 2 μg was reverse-transcribed using qScript cDNA
SuperMix (Quanta Biosciences, Gaithersburg, MD, USA).
Mouse oligonucleotide primer sets were described previ-
ously [16]. Piglet oligonucleotide primer sets, detailed
in Table 1, were designed using NCBI/Primer-BLAST.
Quantitative real-time PCR was performed using Per-
feCTa SYBR Green FastMix with low ROX (Quanta
Biosciences), 8 ng of mouse or piglet cortical cDNA,
and 300 nM of a RT-PCR primer sets (IDT, San Jose,
CA, USA). Settings for analysis using an ABI Fast 7500
machine were as follows: initial denaturation (95°C/
3 min) was followed by 45 cycles of denaturation (95°C/
1 s) and primer annealing (60°C/30 s). A melt curve was
performed on all samples for quality control. Data was
quantified by the 2(−ΔΔCt) method using β-actin or glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) (EC
1.2.1.12) as internal control reference mRNAs [21]. In
the mouse cortical slice experiment, mRNA from three
slices collected at various incubation time points in two
independent experiments (n = 6) was analyzed in tripli-
cate and expressed as mean fold difference ± SEM rela-
tive to baseline levels (time 0) in a freshly isolated
cortex. In the piglet cortical injury experiment (n = 6),
cDNA from individual lesion core, penumbra, 2 cm an-
terior, and contralateral regions were analyzed in tripli-
cate and expressed as average fold difference ± SEM
relative to average levels in contralateral tissues. For
analysis of mRNA changes in individual piglets (n = 6),
CCL2 and PTGS2 (EC 1.14.99.1) mRNAs in penumbra
Table 1 Primer sequences for real-time qPCR analysis of piglet gene expression
mRNA Swine primer sequence (5′ - 3′) Amplicona (bp) Accession #b
IL-1β Fc AGGCACAAAGGCCATTCAGT 102 NM_001005149.1
IL-1β Rc ACTTCCTTGGCAGGTTCAGG
TNF-α F CATCTACCTGGGAGGGGTCT 109 NM_214022.1
TNF-α R ACCTGCCCAGATTCAGCAAA
CCL2 F CACCAGCAGCAAGTGTCCTA 86 NM_214214.1
CCL2 R CCCACTTCTGCTTGGGTTCT
CCL3 F TATTTTGAGACCAGCAGCCAGT 127 NM_001009579.1
CCL3 R CATTCAGCTCCAGGTCAGAGAT
CCL4 F TTCACATACACCGTGCGGAA 148 NM_213779.1
CCL4 R ACTCCTGGACCCAGTCATCA
PTGS2 F CCAGCACTTCACCCATCAGT 132 NM_214321.1
PTGS2 R AGGCGCAGTTTATGCTGTCT
β-actin F CAAGCAGGAGTACGACGAGT 145 XM_003357928.2
β-actin R GGCTGGCATGAGGTGTGTA
GAPDH F AAGGTCGGAGTGAACGGATT 149 NM_001206359.1
GAPDH R CCGTGGGTGGAATCATACTGG
aPredicted number of base pairs (bp) in PCR product; bNCBI reference sequence; cF, forward primer; R, reverse primer. CCL2, chemokine ligand 2; CCL3, chemokine
ligand 3; CCL4, chemokine ligand 4; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IL-1β, interleukin-1β; PTGS2, prostaglandin-endoperoxide synthase 2;
TNF-α, tumor necrosis factor-α.
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and lesion core regions were expressed as fold differ-
ence relative to levels in the contralateral tissue from
the same piglet.
Statistics
GraphPad Prism Software (La Jolla, CA, USA) was used
to generate graphs and conduct statistical analysis. One-
way ANOVA followed by Dunnett’s multiple comparison
test was used for comparisons of various incubation times
relative to baseline amounts in mouse slices. Student’s t
test was used for comparisons of ipsilateral cortical re-
gions relative to uninjured contralateral regions in the pig-
lets. The correlation between the mRNA fold changes
among individual piglets was analyzed by a linear regres-
sion model. Statistical significance was defined as P < 0.05.
Results
Inflammatory gene expression in mouse cortical slices
over time
To analyze the transcriptional changes in cortical slices,
abundance of mRNA was measured in slices incubated
for 0.5, 4.5, 6, and 24 h. Freshly isolated cerebral cortices
were used as the 0 h baseline values. IL-1β and TNF-α
transcripts increased from 0 to 6 h and then decreased
between 6 and 24 h (Figure 1). CCL2-4 and PTGS2
mRNAs increased from 0 to 6 h and remained elevated
at 24 h (Figure 1).
Regional inflammatory gene expression in piglets after
cortical impact, in vivo
We analyzed next the level of inflammatory transcripts
in piglet cerebral cortices after a cortical impact. Tissues
from lesion core, penumbra, and 2-cm anterior to the
penumbra were collected 24 h after injury for compari-
son to cortical tissue collected from the corresponding
region on the uninjured contralateral side. While
GAPDH and β-actin are both stable endogenous refer-
ence genes in uninjured pig cerebral cortex [22], we
found GAPDH (mean critical threshold values across
four cortical regions after injury ± SEM; 19.4 ± 0.1) to be
more stable than β-actin (16.8 ± 0.2) following cortical
injury. GAPDH mRNA was used as an endogenous ref-
erence for piglet tissues. The expressions of CCL2 and
CCL4 mRNAs increased significantly in the lesion core
Figure 1 Expression of inflammatory genes in mouse cortical slices incubated on various times. IL-1β, TNF-α, CCL2, CCL3, CCL4, and PTGS2
mRNAs were measured at 0, 0.5, 4.5, 6, and 24 h in culture. Target mRNAs were normalized to β-actin mRNA as an endogenous control reference,
and differences among the groups were tested with Dunnett’s multiple comparison test. n = 6 per time point. *Means ± SEM differ P < 0.05 relative to
time zero; **means ± SEM differ P < 0.01 relative to time zero. CCL2, chemokine ligand 2; CCL3, chemokine ligand 3; CCL4, chemokine ligand 4; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; IL-1β, interleukin-1β; PTGS2, prostaglandin-endoperoxide synthase 2; TNF-α, tumor necrosis factor-α.
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tissues 24 h after injury (Figure 2). Average levels of IL-
1β, TNF-α, PTGS2, and CCL3 mRNAs appeared ele-
vated, but there was a high degree of variability and
these changes were not statistically significant. CCL2
mRNA also increased in the penumbra region (Figure 3).
No change was found in cortical tissue adjacent to the
penumbra at 2-cm anterior to the injury in the same
hemisphere vs. contralateral hemisphere (data not shown).
Some genes are found to be less stable across individ-
ual outbred pigs even in uninjured cerebral cortex [22].
Therefore, we examined the distribution of the PTGS2
and CCL2 mRNA expressions in cerebral cortex in indi-
vidual piglets. As shown in Table 2, the critical threshold
values in the contralateral hemisphere for CCL2 (range
4.2 to 6.9) reveal less mRNA variability among the pig-
lets in comparison to PTGS2 (4.0 to 9.8). CCL2 mRNA
increased in the penumbra relative to contralateral tissue
levels within the same piglet, whereas changes in PTGS2
were either increased or decreased in different piglets.
No linear correlation between the changes of CCL2 and
PTGS2 mRNAs was found in the penumbra, but a
strong correlation between CCL2 mRNA changes in
penumbra and lesion core was observed (Figure 4).
Discussion
The immunological response to neural injury is predom-
inantly investigated in the in vivo rodent models. Alter-
natively, glia are activated in vitro with endotoxins or
cytokines in dissociated cell culture systems. Yet, therap-
ies identified in current model systems have not easily
translated to clinically effective treatments [23]. Add-
itional preclinical systems will expand our understanding
of the acute inflammatory response to cortical injury
and may facilitate the discovery of pharmacological
agents that attenuate secondary damage. In this study,
we report the transcriptional changes of inflammatory
genes in two cortical injury systems that can help fill the
preclinical translational gaps in knowledge that exist be-
fore and after in vivo rodent models.
Microglia are the resident CNS cells derived from
monocyte/macrophage lineage and are the early re-
sponders to neural injuries. While microglia can be iso-
lated or immortalized for use in highly valuable cell
culture studies, one disadvantage to this system is that
dissociated microglia are separated from their normal
neural contacts. Microglial phenotype and function are
regulated by the unique and complex cellular and extra-
cellular signaling molecules [24]. Studying slices of CNS
tissue ex vivo has the advantage of maintaining glia in
their neural microenvironment, and the sectioning of
tissue causes an immunological response without the re-
quirement of endotoxins. While the change in acute ex-
pression of inflammatory mediators in spinal cord slices
reveals a similar profile to observations in spinal cord in-
jury in the rodents in vivo [25,26], it is not known
whether slices of cerebral cortex will demonstrate a
similar pattern to in vivo models of TBI. The IL-1β and
TNF-α expressions increase in the cortex within the first
few hours in the rodent models of TBI before returning
to baseline levels by 24 h [4,5]. Similarly, the expression
of these cytokines increased in the first 6 h and then de-
creased by 24 h in mouse cortical slices. In the in vivo
rodent models, the expression of chemokines and
PTGS2 increases within hours of cortical injury and, un-
like IL-1β and TNF-α, remains at elevated levels at 24 h
or beyond [7-9]. Remarkably, these particular transcripts
increased early and remained elevated at 24 h in cortical
slices. These findings suggest that cells resident to the
CNS are largely responsible for the acute immunological
response to injury because the ex vivo slice system has
Figure 2 Expression of inflammatory genes in piglet cerebral cortex lesion 24 hours after cortical impact. IL-1β, TNF-α, CCL2, CCL3, CCL4, and
PTGS2 mRNAs in the lesion core were expressed as mean fold change (±SEM) relative to mRNA abundance in cortical tissues from a similar region in
the uninjured contralateral hemisphere. Target mRNAs were normalized to GAPDH mRNA as an endogenous control reference, and differences among
the groups were tested with Student’s t test. *Means ± SEM differ P < 0.05 relative to contralateral region (n = 6). CCL2, chemokine ligand 2; CCL3,
chemokine ligand 3; CCL4, chemokine ligand 4; IL-1β, interleukin-1β; PTGS2, prostaglandin-endoperoxide synthase 2; TNF-α, tumor necrosis factor-α.
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negligible infiltration of leukocytes. The inflammatory
gene expression in slices is regulated by a genetic back-
ground [16] and can be modified by pharmacological
agents in the explant medium [25-27]. The slice system
of cortical injury represents an uncomplicated method
to investigate the early immunological response and is
amendable to transgenic experiments and for screening
of active anti-inflammatory agents that target inflamma-
tory expression at the level of transcription. Future stud-
ies should examine whether expression of cytokines and
chemokines is increased at the protein level, which will
enhance the utility of the cortical slice injury system.
While cortical slices help fill the translational gap be-
tween cell culture and intact rodent models of injury, a
gap in knowledge of acute cortical injury response also
exists between in vivo rodent models and clinical studies
in humans. Swine have gyrencephalic brains similar to
humans in which 50% of the brain is comprised of white
matter in contrast to the lissencephalic rodent brain that
contains 15% white matter. Outbred swine, which are
less expensive than primate species and physiologically
similar to humans, are increasingly being used to study
other trauma and other diseases involving the immune
system such as organ transplant biology as they have
fewer immunologic hurdles to overcome from swine to
human [28]. Swine are increasingly being utilized as
models for pediatric traumatic brain injury [18,29] and
blast injuries in the military [30]. Swine are particularly
useful in understanding TBI in children as the timing of
the peak growth spurt in the piglet occurs around the
time of birth in humans but occurs prior to birth in pri-
mates [15]. TBI superimposed upon development adds
complexity to the problem of therapeutics as therapies
may have the opposite effect in the immature brain
compared to the mature brain and may interfere with
normal development to a greater degree of any benefit
in treating the brain injury [29].
This report demonstrates the early transcriptional in-
flammatory response following cortical injury in piglets.
In agreement with previous findings using outbred swine
[22], which parallel genetic diversity in humans, we
found a high degree of variability in mRNA expression
for some genes. PTGS2 mRNA in the cerebral cortex
was particularly inconsistent in piglets. IL-1β and TNF-α
mRNA levels were also variable in the lesion core 24 h





Piglet Contralateral Penumbra Fold changeb Contralateral Penumbra Fold changeb
#1 6.01 5.30 1.64 4.00 8.15 0.056
#2 6.48 2.49 15.92 4.97 5.43 0.73
#3 6.91 1.56 40.98 7.96 6.09 3.63
#4 4.38 2.24 4.40 7.77 3.94 14.19
#5 4.80 0.77 16.40 8.51 6.32 4.58
#6 4.21 2.38 3.55 9.79 7.15 6.23
aCt = mean critical thresholds of target minus internal control reference; bfold change in penumbra relative to contralateral in individual piglets. CCL2, chemokine
ligand 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PTGS2, prostaglandin-endoperoxide synthase 2.
Figure 3 Expression of PTGS2 and CCL2 in the penumbra region of
piglet cerebral cortex 24 hours after cortical impact. Messenger RNAs in
the adjacent lesion core in the penumbra were expressed as mean fold
change (±SEM) relative to mRNA abundance in cortical tissues from a
similar region in the uninjured contralateral hemisphere. Target mRNAs
were normalized to GAPDH mRNA as an endogenous control reference
and differences among groups tested with Student’s t test. *Means ±
SEM differ P< 0.05 relative to contralateral region (n= 6). CCL2,
chemokine ligand 2; PTGS2, prostaglandin-endoperoxide synthase 2.
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after injury. Since these cytokines increase in the early
hours after injury in the rodent models of TBI before
returning to baseline at 24 h [4,5], future studies should
evaluate IL-1β and TNF-α expressions at earlier time pe-
riods after injury in piglets. Chemokines, on the other
hand, were more stable and represent reliable markers
of acute inflammatory changes in response to injury in
piglets. Increased CCL2 mRNA was found in the lesion
core 24 h after injury. An increase in CCL2 was also
found in the penumbra region, which revealed a positive
linear correlation to changes in the lesion core within
piglets. CCL2, as opposed to PTGS2, may represent a
more reliable biomarker for injury severity and for drug
discovery efforts aimed at regulating the immunological
reaction. Insight into stable and inconsistent inflamma-
tory transcripts in response to TBI in outbred swine may
help in identifying reliable biomarkers useful in the de-
velopment of therapies to overcome the inherent vari-
ability in humans. Here, we initiate study into the
inflammatory response in immature swine and plan on
determining the age-dependent differences in the acute
injury response, which may explain the previously de-
scribed age-dependent lesion size among stages of im-
maturity and reveal age-specific inflammatory targets
[18,19]. Here, we have used injured piglets as their own
control comparing cortical tissue from the ipsilateral vs.
contralateral tissue similar to our previous studies
[18,29]; however, immune modulators may indeed be el-
evated in the contralateral hemisphere thus blunting our
observed increases and perhaps contributing to the vari-
ability among subjects in the contralateral cortical tissue.
Future studies should include sham piglets to determine
if the inflammatory modulators are increased in the cor-
tex contralateral to the impact in this immature, large
animal model of TBI.
New experimental systems to investigate the acute im-
munological reaction may facilitate the discovery of early
interventional drugs to mitigate the disability and fatality
after TBI. In the current study, two disparate mamma-
lian systems of cortical injury illustrate an early increase
in pro-inflammatory transcripts. The mouse cortical
slice system reveals a temporal change in cytokine and
chemokine expressions that is similar to the in vivo
changes reported with the rodent models of TBI. This
slice injury approach can bridge the gap in experimental
systems that exists between higher throughput cell cul-
ture and lower throughput animal models to facilitate
immunotherapeutic discovery and the understanding of
the acute immunological reaction to cortical injury.
Later stages of preclinical development of immunomod-
ulatory drugs would benefit from injury models using
swine, which may more reliably model the brain anat-
omy and subject variability in human studies. The
ex vivo mouse cortical slice injury system and the in vivo
piglet model of brain injury can serve as additional pre-
clinical systems to facilitate the discovery of therapeutic
agents for TBI aimed at regulating early inflammatory
mediator expression.
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